BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1500076)

  • 1. [Pentoxifylline--an inhibitor of the synthesis of tumor necrosis factor alpha].
    Zabel P; Schade FU; Schlaak M
    Immun Infekt; 1992 Jul; 20(3):80-3. PubMed ID: 1500076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of endogenous TNF formation by pentoxifylline.
    Zabel P; Schade FU; Schlaak M
    Immunobiology; 1993 Apr; 187(3-5):447-63. PubMed ID: 8330908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.
    Marques LJ; Zheng L; Poulakis N; Guzman J; Costabel U
    Am J Respir Crit Care Med; 1999 Feb; 159(2):508-11. PubMed ID: 9927365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategies against mediators of septic shock].
    Zabel P; Schade FU
    Immun Infekt; 1993 Apr; 21(2):45-50. PubMed ID: 8340137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline suppression of tumor necrosis factor gene transcription.
    Doherty GM; Jensen JC; Alexander HR; Buresh CM; Norton JA
    Surgery; 1991 Aug; 110(2):192-8. PubMed ID: 1858029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of oral pentoxifylline on the cytokine release syndrome during inductive OKT3.
    DeVault GA; Kohan DE; Nelson EW; Holman JM
    Transplantation; 1994 Feb; 57(4):532-40. PubMed ID: 8116037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.
    Schade UF
    Circ Shock; 1990 Jun; 31(2):171-81. PubMed ID: 2344657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of OKT3-induced tumor necrosis factor alpha formation by pentoxifylline in renal transplant recipients.
    Leimenstoll G; Zabel P; Schroeder P; Schlaak M; Niedermayer W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):561-3. PubMed ID: 8438414
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-alpha production in rat mesangial cell cultures.
    Leithäuser ML; Rob PM; Sack K
    Exp Nephrol; 1997; 5(1):100-4. PubMed ID: 9052855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of tumor necrosis factor-alpha production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-alpha by distinct mechanisms.
    Schmidt-Choudhury A; Furuta GT; Lavigne JA; Galli SJ; Wershil BK
    Cell Immunol; 1996 Jul; 171(1):140-6. PubMed ID: 8660849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia.
    Barton MH; Moore JN
    Circ Shock; 1994 Dec; 44(4):216-20. PubMed ID: 7628064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on effect of pentoxifylline in treatment of extrinsic allergic alveolitis].
    Tong ZH; Chen BM; Dai HP; Wang C; Guzman J; Costabel U
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):482-5. PubMed ID: 15061967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells.
    Neuner P; Klosner G; Schauer E; Pourmojib M; Macheiner W; Grünwald C; Knobler R; Schwarz A; Luger TA; Schwarz T
    Immunology; 1994 Oct; 83(2):262-7. PubMed ID: 7835945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline.
    Schandené L; Gérard C; Crusiaux A; Abramowicz D; Velu T; Goldman M
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):55-6. PubMed ID: 8465427
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentoxifylline protects against endotoxin-induced acute renal failure in mice.
    Wang W; Zolty E; Falk S; Basava V; Reznikov L; Schrier R
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1090-5. PubMed ID: 16985210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
    Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
    Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines.
    Ji Q; Zhang L; Jia H; Xu J
    Ann Clin Lab Sci; 2004; 34(4):427-36. PubMed ID: 15648785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline downregulates nitric oxide and tumor necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line.
    Park E; Schuller-Levis G; Park SY; Jia JH; Levis WR
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):225-33. PubMed ID: 11875767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan.
    Moore JN; Cook JA; Morris DD; Halushka PV; Wise WC
    Circ Shock; 1990 Jul; 31(3):281-95. PubMed ID: 2113440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.